Manager TitleAgeSince
Chief Executive Officer 49 31/05/2025
Director of Finance/CFO 61 31/05/2025
Sales & Marketing 53 01/01/2024
Director TitleAgeSince
Director/Board Member 62 01/01/2020
Chairman 42 01/06/2025
Director/Board Member 75 01/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 717K
+0.08%-4.92%-27.58%+0.61% 167B
+0.94%-2.06%-9.08%+11.62% 111B
+1.14%+0.96%-24.95%+0.42% 105B
+0.52%+0.94%-48.16%-11.25% 74.82B
-1.90%-1.01%-1.54%+69.66% 59.11B
-0.86%+2.96%+13.57%+59.50% 51.8B
-0.66%-3.73%-7.64%-31.34% 48.5B
+0.80%+0.45%-17.71%+21.04% 40.79B
-0.35%-1.00%+29.06%-9.31% 32.54B
Average -3.58%-0.16%-10.45%+12.33% 76.68B
Weighted average by Cap. +0.12%-0.91%-16.47%+9.89%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock